Folic acid fortification and cancer risk

The Lancet

Volumn 371, Issue 9621, 2008, Pages 1335-

  Mason, JB ^a   Cole, BF ^b   Baron, JA ^c   Kim, Y I ^d   Smith, AD ^e  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Vermont ^*  (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; FOLIC ACID BLOOD LEVEL; HUMAN; LAW; LETTER; MEDICAL DECISION MAKING; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION;

EID: 42049112522     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60590-5     Document Type: Letter

References (5)

1. Bayston R., Russell A., Wald N., and Hoffbrand A. Folic acid fortification and cancer risk. Lancet 370 (2007) 2004
2. Mason J., Dickstein A., Jacques P., et al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev 16 (2007) 1325-1329
3. Cole B., Baron J., Sandler R., et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 297 (2007) 2351-2359
4. Ray J., Vermeulen M., Langman L., Boss S., and Cole D. Persistence of vitamin B12 insufficiency among elderly women after folic acid food fortification. Clin Biochem 36 (2003) 387-391
5. Logan R., Grainge M., Shepherd V., Armitage N., and Muir K. Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology 134 (2008) 29-38